Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: USPTO may be due this month, it's not guaranteed, however...

Nov 01, 2007 10:46AM
The J-3 may actually want to settle "before" the USPTO review. If it goes against them, it's a huge nail in their coffin and weakens their bargaining position. It cuts both ways - and since so many other companys believe our patents are valid, the J-3 carry greater risk (than us) on waiting for a USPTO review.
Share
New Message
Please login to post a reply